|
HY-R03503A-20nmol
|
MedChemexpress LLC
|
mMu -miR-680 agomir
|
|
|
|
|
HY-R03503A-5nmol
|
MedChemexpress LLC
|
mMu -miR-680 agomir
|
|
|
|
|
HY-RI03503A-20nmol
|
MedChemexpress LLC
|
mMu -miR-680 antagomir
|
|
|
|
|
HY-RI03503A-5nmol
|
MedChemexpress LLC
|
mMu -miR-680 antagomir
|
|
|
|
|
HY-RI03503-20nmol
|
MedChemexpress LLC
|
mMu -miR-680 inhibitor
|
|
|
|
|
HY-RI03503-5nmol
|
MedChemexpress LLC
|
mMu -miR-680 inhibitor
|
|
|
|
|
HY-R03503-20nmol
|
MedChemexpress LLC
|
mMu -miR-680 mimic
|
|
Cancer-programmed cell death
|
|
|
HY-R03503-5nmol
|
MedChemexpress LLC
|
mMu -miR-680 mimic
|
|
Cancer-programmed cell death
|
|
|
HY-16677A-10mg
|
MedChemexpress LLC
|
Mofegiline (hydrochloride) [CAS 120635-25-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-16677A-100mg
|
MedChemexpress LLC
|
Mofegiline (hydrochloride) [CAS 120635-25-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-16677A-5mg
|
MedChemexpress LLC
|
Mofegiline (hydrochloride) [CAS 120635-25-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-16677A-50mg
|
MedChemexpress LLC
|
Mofegiline (hydrochloride) [CAS 120635-25-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-16677A-1mL
|
MedChemexpress LLC
|
Mofegiline (hydrochloride) [CAS 120635-25-8] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-B0290A-100mg
|
MedChemexpress LLC
|
Pranlukast (hemihydrate) [CAS 150821-03-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-B0290A-50mg
|
MedChemexpress LLC
|
Pranlukast (hemihydrate) [CAS 150821-03-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-B0290A-1mL
|
MedChemexpress LLC
|
Pranlukast (hemihydrate) [CAS 150821-03-7] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-B0290-100mg
|
MedChemexpress LLC
|
Pranlukast [CAS 103177-37-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-B0290-500mg
|
MedChemexpress LLC
|
Pranlukast [CAS 103177-37-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-B0290-1mL
|
MedChemexpress LLC
|
Pranlukast [CAS 103177-37-3] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-10161-100mg
|
MedChemexpress LLC
|
Tozasertib [CAS 639089-54-6]
|
|
Cancer-Kinase/protease
|
|
|
HY-10161-250mg
|
MedChemexpress LLC
|
Tozasertib [CAS 639089-54-6]
|
|
Cancer-Kinase/protease
|
|
|
HY-10161-50mg
|
MedChemexpress LLC
|
Tozasertib [CAS 639089-54-6]
|
|
Cancer-Kinase/protease
|
|
|
HY-10161-1mL
|
MedChemexpress LLC
|
Tozasertib [CAS 639089-54-6] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
|
HY-D1830-1mg
|
MedChemexpress LLC
|
Vari Fluor 680 Carboxylic acid?free acid?
|
|
|
|
|
HY-D1800-1mg
|
MedChemexpress LLC
|
Vari Fluor 680 SE
|
|
|
|
